CREB3L1 Activators are a distinctive class of chemical compounds that specifically enhance the functional activity of the CREB3L1 protein, a transcription factor involved in the regulation of cellular stress responses and metabolism, among other processes. These activators interact with cellular signaling pathways that converge on the activation of CREB3L1, ensuring that its role in gene expression is accentuated. For instance, certain phosphodiesterase inhibitors work by elevating intracellular cAMP levels, which in turn activate protein kinase A (PKA). PKA can phosphorylate the regulatory domains of CREB3L1, thereby increasing its transcriptional activity. This activation mechanism is crucial for the upregulation of genes under CREB3L1 control, particularly those involved in the unfolded protein response (UPR) and lipid biosynthesis. Another example includes activators that modulate calcium signaling within the endoplasmic reticulum (ER). These compounds, by altering the calcium homeostasis, can initiate a signaling cascade that leads to the cleavage and activation of CREB3L1, thus promoting its translocation to the nucleus and subsequent gene expression modulation.
Furthermore, certain small molecules that act as serine/threonine kinase activators also play a role in the regulation of CREB3L1 activity. By enhancing the phosphorylation status of CREB3L1 at specific serine residues, these activators bolster its transcriptional efficacy. Meanwhile, activators that mitigate ER stress indirectly support CREB3L1 activation by reducing inhibitory signals, thus fostering an environment conducive to its full activation. Additionally, compounds that inhibit negative regulators of CREB3L1, such as specific protein phosphatases, result in a sustained activation state of CREB3L1, enhancing its ability to drive the expression of target genes. Collectively, these CREB3L1 Activators orchestrate a fine-tuned regulation of CREB3L1's activity, influencing a wide array of physiological processes that are critical for maintaining cellular homeostasis and responding to cellular stress without altering the protein's expression levels directly.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin raises intracellular cAMP levels, which in turn activates PKA. PKA phosphorylates CREB proteins, thus enhancing the activity of CREB3L1 by promoting its binding to cAMP response elements in DNA and the transcription of downstream genes. | ||||||
Isoproterenol Hydrochloride | 51-30-9 | sc-202188 sc-202188A | 100 mg 500 mg | $28.00 $38.00 | 5 | |
Isoproterenol acts as a beta-adrenergic agonist, increasing cAMP levels and subsequently activating PKA. This activation leads to phosphorylation of CREB3L1, enhancing its transcriptional activity. | ||||||
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
IBMX is a non-selective inhibitor of phosphodiesterases, which prevents the breakdown of cAMP and cGMP, leading to an increase in their levels and the activation of PKA. This indirectly enhances CREB3L1 activity by increasing its phosphorylation state. | ||||||
Rolipram | 61413-54-5 | sc-3563 sc-3563A | 5 mg 50 mg | $77.00 $216.00 | 18 | |
Rolipram is a selective inhibitor of phosphodiesterase 4 (PDE4), which leads to increased cAMP levels, thereby activating PKA and enhancing the phosphorylation and activity of CREB3L1. | ||||||
Sodium Fluoride | 7681-49-4 | sc-24988A sc-24988 sc-24988B | 5 g 100 g 500 g | $40.00 $46.00 $100.00 | 26 | |
Sodium Fluoride acts as a nonspecific phosphatase inhibitor, which can lead to an increase in phosphorylated CREB3L1 by preventing its dephosphorylation, thus enhancing its activity. | ||||||
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
Lithium inhibits glycogen synthase kinase 3 (GSK-3), which can enhance the activity of CREB3L1 indirectly, as GSK-3 inhibition can lead to increased transcriptional activity of CREB proteins. | ||||||
Sp-cAMPS | 93602-66-5 | sc-201571 | 1 mg | $97.00 | 3 | |
Sp-cAMPS is a cell-permeable analog of cAMP that activates PKA. This activation leads to the phosphorylation of CREB3L1, increasing its transcriptional activity. | ||||||
Anisomycin | 22862-76-6 | sc-3524 sc-3524A | 5 mg 50 mg | $99.00 $259.00 | 36 | |
Anisomycin is a protein synthesis inhibitor, which can activate stress-activated protein kinases (SAPKs/JNKs) that can phosphorylate CREB proteins, including CREB3L1, enhancing their activity. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
TPA activates protein kinase C (PKC), which can phosphorylate and activate CREB proteins. This indirect activation enhances the transcriptional activity of CREB3L1. | ||||||
Dibutyryl-cAMP | 16980-89-5 | sc-201567 sc-201567A sc-201567B sc-201567C | 20 mg 100 mg 500 mg 10 g | $47.00 $136.00 $492.00 $4552.00 | 74 | |
Dibutyryl-cAMP is a cell-permeable cAMP analog that activates PKA, leading to increased phosphorylation and activity of CREB3L1. | ||||||